The short answer
An Independent Buyout (IBO) is a sale of your company to a trust held for the benefit of your own employees, financed the same way a private equity firm would finance a leveraged buyout - by borrowing against the business's cash flow. You get liquidity at a market-based valuation. Your leadership team keeps running the company. No outside fund takes a board seat, a veto, or a stake in your strategy.
The financing mechanism isn't new or exotic. It runs on Internal Revenue Code Section 1042, which has been in the federal tax code since 1984 and lets a qualifying seller defer capital gains tax when the buyer is an employee stock ownership trust or an eligible worker-owned cooperative and the proceeds get reinvested on a defined schedule (Cornell Law School, 26 U.S. Code § 1042). Employee ownership itself is unremarkable at this point: the National Center for Employee Ownership counts 6,609 ESOPs covering 15.1 million participants and more than $2 trillion in plan assets as of the 2023 plan year, the most recent Form 5500 data available (NCEO).
What's unusual is not the structure. It's that almost nobody advising owners on an exit has a financial reason to bring it up - which is the subject of a separate piece on why owners are only ever shown two doors.
How the mechanics actually work
Strip away the labels and an IBO has four moving parts.
- A valuation. An independent appraiser sets the price the trust can pay, based on normalized EBITDA and market multiples - the same arithmetic a sponsor runs. If you have never seen that arithmetic done on your business, start with how private equity firms value a company and run your own numbers through the business valuation calculator first.
- A trust. A newly formed employee ownership trust becomes the buyer of record. It has no cash of its own on day one.
- Debt. Lenders advance capital against the company's cash flow. This is the part that mirrors private equity exactly - and it is worth understanding that a sponsor doesn't buy your company with its own money either; it borrows against yours.
- A seller note. Whatever the senior lenders won't fund, the seller typically finances at an agreed rate, paid down out of future cash flow.
The difference between an IBO and a leveraged buyout is not the leverage. It's who owns the equity on the other side of the closing, and therefore who controls the company afterward.
A worked example
Take a hypothetical specialty manufacturer with $8 million of normalized EBITDA. The numbers below are invented to show the shape of the structure; they are not a quote, a projection, or a description of any actual transaction.
At a 6.5x multiple, the enterprise value is $52 million. Lower-middle-market debt capacity commonly lands in the 3x-4x EBITDA range, so assume lenders will advance 3.5x, or $28 million, against the business. The remaining $24 million is carried as a seller note, amortized over several years at a negotiated interest rate.
| Component | Illustrative amount | Who bears the risk |
|---|---|---|
| Enterprise value (6.5x $8M EBITDA) | $52,000,000 | Set by independent appraisal |
| Third-party debt at close (3.5x) | $28,000,000 | Lenders, secured by company cash flow |
| Seller note | $24,000,000 | Seller, paid from future cash flow |
| Forced equity rollover | $0 | Not a feature of the structure |
| Buyer-set earn-out | $0 | Not a feature of the structure |
Now run the same $52 million through a conventional sponsor deal. A 20% required rollover leaves $10.4 million reinvested rather than banked. Federal tax on the cash portion runs about 23.8% at the top bracket - 20% long-term capital gains plus the 3.8% net investment income tax, which applies above $200,000 of modified AGI for a single filer and $250,000 filing jointly (IRS). State tax stacks on top. The fuller side-by-side, including earn-out risk, is laid out in the IBO vs. private equity numbers comparison.
Two things drive most of the gap. The first is that the rollover slice isn't yours to spend - and what happens to rollover equity over a sponsor's hold period is the part sellers consistently misjudge. The second is timing: median private equity holding periods at exit reached roughly 5.4 years globally in 2024, with average holds at exit near seven years for 2025 buyout assets, so "the second bite" is a payout you wait most of a decade for, on someone else's schedule (Capital Pad, citing Bain and Preqin data).
What Section 1042 actually requires
The tax treatment is the piece most owners have never heard of, and it is also the piece most often described loosely. Here is what the statute says.
- The buyer has to be an ESOP or an eligible worker-owned cooperative, and it must own "at least 30 percent" of each class of outstanding stock, or of the total value of all outstanding stock, immediately after the sale (26 U.S.C. § 1042).
- The stock has to be "qualified securities" - employer securities of a domestic corporation with no readily tradable stock.
- The proceeds have to be reinvested in qualified replacement property: securities of a domestic operating corporation that isn't the company you just sold and that didn't have passive investment income above 25% of gross receipts in the preceding year.
- The reinvestment window is 15 months - it opens three months before the sale closes and shuts 12 months after.
Meet those conditions and the gain is deferred, not erased. Deferral is still a large economic difference when it applies to the whole proceeds rather than a slice, but it is not a tax exemption, and whether any of it applies turns entirely on your own facts. Confirm the treatment with your own tax advisor before you build a plan around it.
IBO, MBO, ESOP, PE: how they differ
These four get used interchangeably in conversation and they are not the same thing.
| Structure | Who buys | How it's funded | Who controls the company after close |
|---|---|---|---|
| Private equity sale | An outside fund | Acquisition debt on your balance sheet plus fund equity | The sponsor, via board seats and veto rights |
| Management buyout (MBO) | Your leadership team personally | Management's own capital, seller notes, bank and mezzanine debt | Management, subject to lender covenants |
| Employee stock ownership plan | A trust for employees | Company or seller borrowing, repaid from cash flow | The trustee, with a board it appoints |
| Independent Buyout (IBO) | A trust for employees | Third-party leverage sized like an LBO, plus a seller note | Existing leadership, with no outside sponsor |
The practical distinction between an IBO and a garden-variety management buyout is capital. Management teams rarely have the personal balance sheet to fund a full purchase price, which is why MBOs so often stall at a partial deal or a heavily deferred one. Sizing the debt the way a sponsor would sizes the seller's payout the way a sponsor would.
The distinction from a private equity minority recap is control. A sponsor holding even a minority position typically negotiates veto rights over financing, acquisitions, and the timing of any future sale. In an IBO there is no counterparty holding those rights.
Where an IBO doesn't fit
It is not a universal answer, and any advisor who tells you otherwise is selling something.
The structure depends on the business servicing acquisition debt, so it needs meaningful, stable cash flow - generally $3 million or more of EBITDA, and a company whose earnings don't swing violently with one customer or one commodity. It needs a leadership team capable of running the business without you, which is a multi-year project if it isn't already true. If your best offer is a strategic buyer paying a genuine synergy premium well above the financial-buyer range, that premium may simply be worth more than the control and tax advantages of an IBO. And the transaction costs of setting up and administering a trust are real, which is part of why the structure doesn't scale down to small businesses. A candid comparison against every other exit option on the board is the right starting point, not a foregone conclusion.
Frequently asked questions
What does IBO stand for? Independent Buyout. It describes a sale in which the company's own employees, through a trust, become the buyer, financed with the same leverage a private equity firm would use.
Do I have to sell 100% of the company? No. Section 1042 requires the trust to hold at least 30% of the stock immediately after the sale to qualify for deferral, but a seller can structure a partial sale above that threshold and retain the balance.
Is an Independent Buyout the same as an ESOP? The trust mechanism and the tax code section overlap, but the design intent differs. A conventional ESOP is usually built and marketed as a retirement benefit funded gradually out of company cash flow. An IBO is structured as a liquidity event - the debt is sized against the business the way an LBO would be, so the seller's payout resembles a sponsor deal rather than a slow internal transfer.
Who runs the company after the sale? Your existing leadership team. That is the point of the structure: there is no outside fund appointing directors, setting earn-out targets, or deciding when the company gets sold next.
How big does my company need to be? As a general guide, $3 million or more in EBITDA, because the financing depends on cash flow that can carry acquisition debt. Every business's facts determine what is actually achievable.
Is the tax deferral guaranteed? No. Section 1042 deferral depends on the buyer's post-sale ownership percentage, the type of stock sold, and reinvestment in qualified replacement property inside the 15-month window. Confirm your own situation with a tax advisor.
Sources
- 26 U.S. Code § 1042 - Cornell Law School Legal Information Institute
- National Center for Employee Ownership - "Employee Ownership by the Numbers"
- IRS - "Questions and Answers on the Net Investment Income Tax"
- Capital Pad - "Private Equity Holding Periods Are Lengthening"
The bottom line
An Independent Buyout is a leveraged buyout where the buyer happens to be your own people. The valuation math is the same, the debt is the same, and the liquidity can be comparable - what changes is that nobody outside the company ends up holding a veto over it, and that the tax code has had a provision encouraging exactly this since 1984.
If your company is doing $3M+ in EBITDA and you want to know whether an Independent Buyout beats the offer you've already been shown, talk to IBO Advisors about your specific business.
Curious whether an Independent Buyout fits your business?
Learn More